ATA WATCH in the news this week:
Frontiers magazine: "As HIV morphs into a manageable illness, who manages the companies responsible for continued research, drug development, and advocacy?"
AIDSmeds.com: "Those representing the interests of people with HIV are too dependent on pharmaceutical funding," ATA Watch founder charges
With the long-term well-being of HIV+ patients increasingly at odds with the interests of profit-maximizing drug and diagnostic companies, reliance on good intentions and an arbitrarily enforced code
of honor is no longer an adequate safeguard against the temptations for abuse.
A
small group of veteran activists, community physicians and PR pros decided it was time to shine a little light.
Thus was born the AIDS Transparency & Accountability Watch: Shining light on pharma, physician and advocacy group relations.